相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disease recurrence patterns after R0 resection of hilar cholangiocarcinoma
A. Kobayashi et al.
BRITISH JOURNAL OF SURGERY (2010)
Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies
Ioannis Hatzaras et al.
HPB (2010)
CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions
Daniele Marrelli et al.
AMERICAN JOURNAL OF SURGERY (2009)
Adjuvant therapy for resected extrahepatic cholangiocarcinoma: A review of the literature and future directions
Carryn Anderson et al.
CANCER TREATMENT REVIEWS (2009)
Prognostic Factors for Gallbladder Cancer in Japan
Masato Kayahara et al.
ANNALS OF SURGERY (2008)
Circulating markers of biliary malignancy: opportunities in proteomics?
Glenn K. Bonney et al.
LANCET ONCOLOGY (2008)
Prognostic relevance of carbohydrate antigen 19-9 levels in patients with advanced biliary tract cancer
Jan Harder et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer
Chang Moo Kang et al.
JOURNAL OF SURGICAL RESEARCH (2007)
The role of adjuvant radiotherapy in microscopic tumor control after extrahepatic bile duct cancer surgery
Dongryul Oh et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2007)
Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery
Shiro Miwa et al.
JOURNAL OF GASTROENTEROLOGY (2006)
The number of metastatic lymph nodes in extrahepatic bile duct carcinoma as a prognostic factor
SM Hong et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Prognostic factors of surgical resection in middle and distal bile duct cancer: An-analysis of 55 patients concerning the significance of ductal and radial margins
Y Sakamoto et al.
SURGERY (2005)
Serum and bile markers for cholangiocarcinoma
O Nehls et al.
SEMINARS IN LIVER DISEASE (2004)
Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma - Implications for adjuvant therapeutic strategies
WR Jarnagin et al.
CANCER (2003)
Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line
JH Yoon et al.
GASTROENTEROLOGY (2002)
Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies
AE Sirica et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice
DV Mann et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2000)
分享论文
